English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 44607/57715 (77%)
造訪人次 : 1621526      線上人數 : 136
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/63435


    題名: 利用液相層析串聯質譜儀建立和驗證人血清中尿毒症毒素硫酸??酚和對甲酚基硫酸鹽的方法
    Establishment and validation for uremic toxin indoxyl sulfate and p-cresol sulfate in human serum by using LC-MS/MS method
    作者: 呂守正
    LU, SHOU-CHENG
    貢獻者: 醫學檢驗暨生物技術學系碩士在職專班
    劉俊仁
    關鍵詞: 液相層析串聯質譜儀;硫酸??酚;甲酚基硫酸鹽
    LC-MS/MS;indoxyl sulfate;p-cresol sulfate
    日期: 2023-07-03
    上傳時間: 2024-01-22 13:22:57 (UTC+8)
    摘要: 目的:慢性腎臟病患者腎功能的惡化和尿毒素具有相當高的相關性,因為尿毒素會誘發炎症反應與增加氧化壓力,導致腎絲球硬化與腎間質纖維化,加重腎功能的衰退。依據2021年台灣腎病年報指出台灣透析發生率及盛行率居高不下,2019年臺灣透析盛行患者數共86,840 人,相較2015年上升11.7 %。近年來有許多研究證明硫酸??酚(indoxyl sulfate,以下簡稱IS)和對甲酚基硫酸鹽(p-cresol sulfate,以下簡稱pCS)對於早期發現腎臟病有直接相關。本研究旨在利用液相層析串聯質譜儀建立和驗證人血清中硫酸??酚和對甲酚基硫酸鹽的方法供臨床檢驗使用。
    方法:樣品經蛋白質沉澱處理後注射於層析儀,接著利用電噴灑方式進入偵測器,並以多重反應監控模式偵測質荷比,透過固定相滯留時間之長短,於層析圖呈現之波峰面積進行定量,每一檢體分析時間為5.5分鐘。
    結果:(1)線性分析(Linearity):IS與pCS的線性相關係數皆大於0.995;(2)精密度分析(Precision):within day變異係數皆小於3.6%,between day變異係數皆小於6.8%;(3)專一性分析(Specificity):IS與pCS其保留時間(Retention Time)分別為1.76±0.02與2.15±0.01可以很清楚地在分析圖譜上分別開來;(4)基質效應分析(Matrix effect):IS為86.9 %~110.5 %,pCS為95.6 %~101.0 %;(5)最低定?濃?(Limit of quantitation):IS與pCS均可達到0.001 ppm, 其中IS訊號雜訊比為143,pCS訊號雜訊比為391。
    結論:我們驗證了一種快速,靈敏的液相層析串聯質譜儀的檢驗方法,可用於定量測定血清中IS和pCS的濃度,將可提供臨床上早期發現腎臟病的可能性。
    Purpose:The deterioration of renal function in patients with chronic kidney disease has a high correlation with uremic toxins, because uremic toxins can induce inflammation and increase oxidative stress, leading to glomerulosclerosis and renal interstitial fibrosis, aggravating the decline of renal function.According to the 2021 Taiwan Kidney Disease Annual Report, the incidence and prevalence of dialysis in Taiwan remain high. In 2019, the number of patients with dialysis in Taiwan was 86,840, an increase of 11.7% compared to 2015.In recent years, many studies have proved that indoxyl sulfate (hereinafter referred to as IS) and p-cresol sulfate (hereinafter referred to as pCS) are directly related to the early detection of kidney disease. This study aims to establish and validate a method for indoxyl sulfate and p-cresol sulfate in human serum using liquid chromatography tandem mass spectrometry for clinical testing.
    Method:The sample was injected into the chromatograph after protein precipitation, and then entered the detector by electrospray, and the mass-to-charge ratio was detected by the multiple reaction monitoring mode. The retention time of the stationary phase was displayed in the chromatogram. The peak area was quantified, and the analysis time for each sample was 5.5 minutes.
    Results:(1) Linearity analysis:the IS and pCS linear correlation coefficients were both greater than 0.995;(2) Precision analysis:the intra-day coefficients of variation were all less than 3.6%, and the inter-day coefficients of variation were all less than 6.8%;(3) Specificity analysis:The retention time of IS and pCS is 1.76±0.02 and 2.15±0.01 respectively, which can be clearly separated on the analysis spectrum; (4) Matrix effect analysis:IS was 86.9 %~110.5 %, pCS was 95.6 %~101.0 %;(5) The Limit of quantitation:IS and pCS can reached 0.001 ppm, of which the signal-to-noise ratio of IS was 143, and the signal-to-signal ratio of pCS was 391.
    Conclusions:We validated a rapid and sensitive liquid chromatography tandem mass spectrometry method for the quantitative determination of IS and pCS concentrations in serum, which will provide the possibility of early detection of renal disease clinically.
    描述: 碩士
    指導教授:劉俊仁
    委員:李麗花
    委員:楊沂淵
    委員:劉俊仁
    資料類型: thesis
    顯示於類別:[醫學檢驗暨生物技術學系所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML42檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋